Publications by authors named "Koichi Nishimura"

Claim this Profile
I
Impact of starting dose of tyrosine kinase inhibitors on outcomes following combination therapy of immune checkpoint inhibitors with tyrosine kinase inhibitors for previously untreated advanced renal cell carcinoma.
Hiroki Ishihara, Koichi Nishimura, Yuki Nemoto, Shinsuke Mizoguchi, Takayuki Nakayama

Jpn J Clin Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Complete Remission of Bilateral Upper Tract Carcinoma In Situ Following Retrograde Bacillus Calmette-Guérin (BCG) Instillation via Open-Ended Ureteral Catheters After Failure Using Double-J Stents.
Nanaka Katsurayama, Toshihide Horiuchi, Koichi Nishimura, Kazutaka Nakamura, Takanori Endo

IJU Case Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of nivolumab plus cabozantinib in octogenarian patients with advanced renal cell carcinoma.
Yuki Nemoto, Takanori Endo, Hogara Segawa, Kazutaka Nakamura, Koichi Nishimura

Int Urol Nephrol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term real-world outcomes of nivolumab plus ipilimumab for advanced renal cell carcinoma: a minimum of 4-years follow-up study.
Hiroki Ishihara, Koichi Nishimura, Yuki Nemoto, Shinsuke Mizoguchi, Takayuki Nakayama

Jpn J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of first-line dual immuno-oncology combination therapy versus immuno-oncology plus tyrosine kinase inhibitor on outcomes of second-line VEGFR-TKI in advanced RCC: a real-world multi-institutional analysis.
Koichi Nishimura, Hiroki Ishihara, Yuki Nemoto, Shinsuke Mizoguchi, Takayuki Nakayama

Int Urol Nephrol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High real-world incidence of hepatic dysfunction from cabozantinib plus nivolumab for Japanese patients with metastatic renal cell carcinoma.
Toshihide Horiuchi, Koichi Nishimura, Kazutaka Nakamura, Yuki Nemoto, Yudai Ishiyama

Jpn J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of age on treatment outcomes of first-line immune checkpoint inhibitor combination therapy for previously untreated advanced renal cell carcinoma.
Hiroki Ishihara, Koichi Nishimura, Yuki Nemoto, Shinsuke Mizoguchi, Takayuki Nakayama

Geriatr Gerontol Int· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Polypharmacy on Perioperative Outcomes of Robot-assisted Laparoscopic Partial Nephrectomy for Small Renal Masses.
Yuki Nemoto, Hiroki Ishihara, Kazutaka Nakamura, Koichi Nishimura, Hironori Fukuda

In Vivo· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health status, respiratory symptom and dyspnea trajectories in subjects with chronic obstructive pulmonary disease: a seven-year observation in clinical practice.
Koichi Nishimura, Masaaki Kusunose, Ayumi Shibayama, Kazuhito Nakayasu

J Patient Rep Outcomes· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship Between COPD Progression and Frailty Progression: A Five-year Observation in Real Clinical Practice.
Koichi Nishimura, Masaaki Kusunose, Ayumi Shibayama, Kazuhito Nakayasu

Int J Chron Obstruct Pulmon Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Analysis of Outcomes for Patients With Advanced Renal Cell Carcinoma: Immuno-Oncology Era Tyrosine Kinase Inhibitor Era in the IMDC Favorable-risk Group.
Hiroki Ishihara, Yuki Nemoto, Shinsuke Mizoguchi, Koichi Nishimura, Hironori Fukuda

Anticancer Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole exome sequencing identified mutations of forkhead box I 1 (FOXI1), keratin 6 C (KRT6C) and gap junction protein delta 2 (GJD2) in a low-grade oncocytic tumor of the kidney: a case report.
Akinari Kakumoto, Koichi Nishimura, Daisuke Toki, Rika Kasajima, Hajime Kuroda

Diagn Pathol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in outcome of patients with advanced non-clear cell renal cell carcinoma from the tyrosine kinase inhibitor era to the immuno-oncology era.
Hiroki Ishihara, Yuki Nemoto, Shinsuke Mizoguchi, Koichi Nishimura, Takashi Ikeda

Int J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma.
Hiroki Ishihara, Koichi Nishimura, Takashi Ikeda, Hironori Fukuda, Kazuhiko Yoshida

Urol Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesna, Doxorubicin, Ifosfamide and Dacarbazine (MAID) Combination Chemotherapy for Retroperitoneal Sarcoma: A Single-center Experience.
Yudai Ishiyama, Toru Inakawa, Maki Yoshino, Koichi Nishimura, Toshihide Horiuchi

Anticancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty and Exacerbation of Chronic Obstructive Pulmonary Disease: Is There Any Association?
Koichi Nishimura, Masaaki Kusunose, Ryo Sanda, Ayumi Shibayama, Kazuhito Nakayasu

Int J Chron Obstruct Pulmon Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data.
Hiroki Ishihara, Kenji Omae, Yuki Nemoto, Ryo Ishiyama, Hidekazu Tachibana, Koichi Nishimura

Int J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Disease Severity Classifications of Chronic Obstructive Pulmonary Disease: GOLD vs. STAR in Clinical Practice.
Koichi Nishimura, Masaaki Kusunose, Ayumi Shibayama, Kazuhito Nakayasu

Diagnostics (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Frailty a Mortality Predictor in Subjects with Chronic Obstructive Pulmonary Disease?
Koichi Nishimura, Masaaki Kusunose, Ayumi Shibayama, Kazuhito Nakayasu

Int J Chron Obstruct Pulmon Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Cytokine Release Syndrome on Cardiac Function After Chimeric Antigen Receptor-T Cell Therapy.
Isamu Sunayama, Kyung-Duk Min, Yoshiyuki Orihara, Makiko Oboshi, Satoshi Yoshihara, Koichi Nishimura

JACC Asia· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mean pulmonary artery pressure estimated by echocardiogram rapidly exceeds 20 mmHg from the normal range in patients with connective tissue disease.
Yoshiyuki Orihara, Masanori Asakura, Kyung-Duk Min, Yuki Matsumoto, Isamu Sunayama, Koichi Nishimura

Heart Vessels· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effect of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a randomised controlled trial.
Kensuke Kataoka, Osamu Nishiyama, Takashi Ogura, Yoshihiro Mori, Ryo Kozu, Koichi Nishimura

Thorax· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Special Issue "Diagnosis, Treatment, and Management of COPD and Asthma".
Koichi Nishimura

Diagnostics (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Predictive Properties between Tools of Patient-Reported Outcomes: Risk Prediction for Three Future Events in Subjects with COPD.
Koichi Nishimura, Masaaki Kusunose, Ryo Sanda, Mio Mori, Ayumi Shibayama

Diagnostics (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Conceptual Independence of Health Status, Respiratory Symptoms and Dyspnea in Chronic Obstructive Pulmonary Disease in Real Clinical Practice.
Koichi Nishimura, Masaaki Kusunose, Mio Mori, Ayumi Shibayama, Kazuhito Nakayasu

Diagnostics (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis